Fineline Cube

Follow:
14409 Articles
TenNor Therapeutics Partners with Grand Life Sciences for Rifasutenizol Commercialization in China
CompanyDeals

TenNor Therapeutics Partners with Grand Life Sciences for Rifasutenizol Commercialization in China

Immunochina Pharmaceuticals' IM19 CAR-T Therapy Accepted for Review by NMPA
CompanyDrug

Immunochina Pharmaceuticals’ IM19 CAR-T Therapy Accepted for Review by NMPA

Thederma’s TAP-1503 Cream Approved by China’s NMPA for Atopic Dermatitis Treatment
CompanyDrug

Thederma’s TAP-1503 Cream Approved by China’s NMPA for Atopic Dermatitis Treatment

Novartis's Kisqali Approved by EC for Adjuvant Treatment of High-Risk Early Breast Cancer
CompanyDrug

Novartis’s Kisqali Approved by EC for Adjuvant Treatment of High-Risk Early Breast Cancer

Sanofi Launches Modulus, a Pioneering Manufacturing Facility in Singapore
Company

Sanofi Launches Modulus, a Pioneering Manufacturing Facility in Singapore

Chia Tai Tianqing's Benmelstobart Combo Approved by NMPA for Endometrial Cancer Treatment
CompanyDrug

Chia Tai Tianqing’s Benmelstobart Combo Approved by NMPA for Endometrial Cancer Treatment

Sichuan Kelun-Biotech's SKB264/MK-2870 Approved by NMPA for Triple Negative Breast Cancer
CompanyDrug

Sichuan Kelun-Biotech’s SKB264/MK-2870 Approved by NMPA for Triple Negative Breast Cancer

NHC Aims for Nationwide Inspection Result Sharing in Medical Consortia by 2030
Policy / Regulatory

NHC Aims for Nationwide Inspection Result Sharing in Medical Consortia by 2030

Ji Xing Pharmaceuticals' Varenicline Nasal Spray Gains NMPA Approval for Xerophthalmia
CompanyDrug

CORXEL’s Varenicline Nasal Spray Approved by NMPA for Dry Eye Treatment

Arrowhead and Sarepta Seal $11.38 Billion Global Licensing Deal for Rare Disease Treatments
CompanyDeals

Arrowhead and Sarepta Seal $11.38 Billion Global Licensing Deal for Rare Disease Treatments

Pfizer Partners with CR Pharma to Expand Cancer Drug Access in China
CompanyDrug

Pfizer Partners with CR Pharma to Expand Cancer Drug Access in China

Roche’s Evrysdi Receives Patent Term Extension in China, Extending Protection to 2035
Legal / IP

Roche’s Evrysdi Receives Patent Term Extension in China, Extending Protection to 2035